mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |